您当前的位置: 首页 > 资源详情

Nature Communications,10月29日,Anti-spike antibody response to natural SARS-CoV-2 infection in the general population

编译者:YUTING发布时间:Nov 5, 2021点击量:32 来源栏目:最新研究

Understanding the trajectory, duration, and determinants of antibody responses after SARS-CoV-2 infection can inform subsequent protection and risk of reinfection, however large-scale representative studies are limited. Here we estimated antibody response after SARS-CoV-2 infection in the general population using representative data from 7,256 United Kingdom COVID-19 infection survey participants who had positive swab SARS-CoV-2 PCR tests from 26-April-2020 to 14-June-2021. A latent class model classified 24% of participants as ‘non-responders’ not developing anti-spike antibodies, who were older, had higher SARS-CoV-2 cycle threshold values during infection (i.e. lower viral burden), and less frequently reported any symptoms. Among those who seroconverted, using Bayesian linear mixed models, the estimated anti-spike IgG peak level was 7.3-fold higher than the level previously associated with 50% protection against reinfection, with higher peak levels in older participants and those of non-white ethnicity. The estimated anti-spike IgG half-life was 184 days, being longer in females and those of white ethnicity. We estimated antibody levels associated with protection against reinfection likely last 1.5-2 years on average, with levels associated with protection from severe infection present for several years. These estimates could inform planning for vaccination booster strategies.

提供服务:导出本资源
  1. 1 Nature,11月10日,Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility
  2. 2 11月10日_研究人员分析宿主基因对COVID-19严重程度和易感性的影响
  3. 3 11月11日_新冠药物Remestemcel-L二期临床的中期分析结果积极
  4. 4 11月11日_CDC呼吁制定通用口罩规定以减少新冠传播
  5. 5 SSRN,2月20日,Dynamics of the Latest 2019 Novel Coronavirus Disease Epidemic in China: A Descriptive Study
  6. 6 SSRN,2月20日,Mental Health Problems and Social Media Exposure During COVID-19 Outbreak
  7. 7 SSRN,2月20日,Evaluating Incidence and Impact Estimates of the Coronavirus Outbreak from Official and Non-Official Chinese Data Sources
  8. 8 SSRN,2月20日,Clinical Characteristics and Treatment of Patients Infected with COVID-19 in Shishou, China
  9. 9 Nature,11月10日,Mobility network models of COVID-19 explain inequities and inform reopening
  10. 10 1月27日_Nature报道中国新型冠状病毒最新研究进展:病毒传播速度有多快?
  1. 1 Medicalxpress,1月10日,Even symptom-free, people with Omicron are much more likely to spread COVID, say studies
  2. 2 Medicalxpress,1月10日,Researchers use artificial intelligence to guide the search for the next SARS-like virus
  3. 3 1月6日_COVID-19患者味觉改变可能是鼻后嗅觉功能受损的间接结果
  4. 4 Medicalxpress,1月7日,Omicron resistant to most monoclonal antibodies but neutralized by a booster dose
  5. 5 Science,1月6日,Antibody-mediated broad sarbecovirus neutralization through ACE2 molecular mimicry
  6. 6 Biospace,1月5日,Clover Doses First Participants with Homologous Booster Dose of COVID-19 Vaccine Candidate in SPECTRA
  7. 7 Medicalxpress,1月4日,Early data for multivariant COVID-19 vaccine booster shows promise
  8. 8 Cell,1月3日,SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses
  9. 9 Medicalxpress,12月30日,Research team discovers a novel vaccine strategy to prevent SARS-CoV-2 nasal infection
  10. 10 Cell,12月27日,Complement activation induces excessive T cell cytotoxicity in severe COVID-19

版权所有@2017中国科学院文献情报中心

制作维护:中国科学院文献情报中心信息系统部地址:北京中关村北四环西路33号邮政编号:100190